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Dietary Energy Restriction (DER) has been shown 
to be chemopreventive against prostate cancer 
although the mechanism remains elusive.  We 
hypothesized that reduced plasma glucose levels 
resulting from DER might play a role in inhibiting 
prostate cancer cell growth and cell signaling. To 
address this hypothesis, we used human PC-3 
cells to study the effects of glucose on these 
parameters.  PC-3 cells exhibit hyperactivity of the 
mTOR cellular energy sensing pathway which is 
associated with increased cell survival. To assay 
mTOR activity, we performed immunoblotting for 
phospho- rp-S6, a downstream target of mTOR.  
We observed a dose-response between 0- 6.25 
mM glucose.  Upon glucose removal, 
phosphorylation of rp-S6 decreases rapidly, with a 
significant effect seen at one hour and abolished 
almost completely at 18 hours.  To confirm that 
this is a reversible phosphorylation event, we 
deprived PC-3 cells of glucose for one hour and 
refed them with 25mM glucose.  Restoration of rp-
S6 phosphorylation levels occurred within 15 
minutes of treatment.  We then investigated if the 
effect seen at 18 hours was due to an increase in 
cell death and whether or not we could rescue 
phosphorylation status.  We deprived cells of 
glucose for 18 hours and refed with 25mM 
glucose.  The time required to restore 
phosphorylation of rp-S6 was increased as 
compared to the one hour fast.  Physiologically, 
we see a decrease in cell viability only after 48 
hours and lowest concentrations of glucose.  In 
conclusion, glucose removal reduces the activity 
of the mTOR pathway in prostate cancer cells.
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Materials. Polycolonal phospho-rp-S6 and 
monocolonal rp-S6 antibodies were purchased from 
Cell Signaling Technology (Beverly, MA)Thiazolyal
Blue Tetrazolium(MTT) was purchased from Sigma-
Aldich(St.Louis, MA).
Cell culture. Human PC-3 prostate cancer cells were 
purchased from ATCC.  Cells were maintained in 
Dulbecco’s Modified Eagle (DMEM) growth medium 
supplemented with 10% fetal bovine serum, sodium 
pyruvate, glutamine and penicillin/streptomycin, and 
kept at 37º C in 5% CO2. For glucose treatment 
experiments, cells were seeded and allowed to attach 
overnight.  All experiments were performed in serum 
free medium. 
Immunoblotting. Proteins were separated using 
SDS-PAGE.  The expression of rp-S6 and total rp-S6 
were determined by immnunoblotting according to the 
manufacturer’s instructions (Cell Signaling).  
MTT- Cells were seeded in a 96 well dish and allowed 
to attach overnight.  Prior to treatment, the cells were 
serum-starved for one hour.  Treatments lasted for 18, 
24 and 48 hours.  After treatment, cell viability was 
measured using the MTT assay according to the 
manufacturer’s instructions (Sigma-Aldrich).
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ABSTRACT OBJECTIVES
HYPOTHESIS
¾To investigate the effects of 
reduced plasma glucose seen with 
Dietary Energy Restriction on the 
mTOR pathway in human prostate 
cancer cells.
¾To investigate the effects of 
varying glucose concentration 
and/or time without glucose on cell 
proliferation and survival.
Glucose regulates rp-S6 phosphorylation in both a time- and dose-
dependent manner
Low concentrations of Glucose decrease cell viability
p-rpS6
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Prostate cancer is the most common 
malignancy among men.  It is also the second 
leading cause of cancer morbidity in men.  
Prostate cancer is characterized by a long 
latency period for cancer progression and 
development of metastasis.  Since the side 
effects of surgery and radiotherapy are 
associated with significant morbidity, other 
treatment options are desirable during this 
period.  This presents an excellent 
chemopreventive opportunity.
Dietary Energy Restriction (DER) has 
been found to be chemopreventive against 
several types of cancer including mammary and 
prostate in animal models.  There is evidence 
that DER acts through modulation of hormones 
and growth factors like IGF-1 and insulin.  
However, several studies have shown that the 
effects are independent of the growth factor 
axis(1).  Thus, the mechanism behind the 
chemopreventive effects of DER remains 
elusive.    
Since tumors grow rapidly, they rely 
heavily on nutrient supply for energy to fuel this 
growth process.  It is possible that decreasing 
cellular energy levels will halt the tumor growth 
and will lead to regression.  On a molecular 
level, this may be accomplished through 
decreased flux through several pathways that 
govern cell growth and proliferation.
PTEN tumor suppressor mutations are 
among the most common mutations seen in 
prostate cancer(2).  Loss of PTEN is associated 
with increased levels of activated Akt.  Akt will 
then activate a downstream target, mTOR.  Its 
activation is associated with apoptosis evasion, 
increased cell growth and angiogenesis(3).  
These features are associated with poor 
prognostic outcome. mTOR has been implicated 
as a sensor of cellular energy status(4).  
Inhibition of mTOR leads to a decrease in total 
protein synthesis, a decrease in cell growth and 
an increase in autophagic cell death.  This 
mimics a starvation-like response.  It has also 
been shown that mTOR responds to 
manipulation of certain nutrients(5).  Since this 
pathway is important in prostate cancer, its 
manipulation may be a key to prostate cancer 
chemoprevention.  Therefore, we believe that 
DER will act through this pathway and we will 
measure key components of this regulatory 
pathway.
In this study, we altered glucose levels 
and glucose exposure time to simulate lowered 
plasma glucose levels that are associated with 
DER.  We used human PC-3 cells which have 
PTEN mutations characterized by high basal 
mTOR activity.  To examine the effects on the 
mTOR pathway, we examined phosphorylation 
status of ribosomal protein S6, which is active 
when phosphorylated and indicative of protein 
translation(6).
p-rpS6
¾Glucose is able to modulate the 
mTOR pathway in both a time 
and dose dependent manner as 
evidenced by alterations in rp-S6 
phosphorylation.
¾rp-S6 phosphorylation is a 
tightly regulated reversible event 
catalyzed by the addition and 
removal of glucose.
¾Glucose affects cell viability at 
low concentrations.
Figure 3- Glucose refeeding restores rp-S6 
phsosphorylation that is lost as a result of glucose 
removal. Cells were serum-starved for 1 hour prior to 
glucose removal.  B=baseline level.  Cells were then glucose 
starved for 1 hour and then treated with 25mM glucose or 
PBS for 15 minutes, 30 minutes, 1 hour or 2 hours. Cell 
lysates were run on a 12% Tris-Glycine SDS-PAGE gel.  
Both phospo- and total rp-S6 were analyzed using 
immunoblotting.
Figure 1-Glucose regulated dose-response increase in 
rp-S6 phosphorylation in PC-3 cells after 18 hours of 
treatment.  Cells were serum-starved for 1 hour prior to 
treatment and the respective glucose concentration was 
added.  Cell lysates were run on a 12% Tris-Glycine SDS-
PAGE gel.  Both phospo- and total rp-S6 were analyzed 
using immunoblotting.
Figure 2- Time course for rp-S6 dephosphorylation in PC-
3 cells after removal of glucose. Cells were serum-starved 
for 1 hour prior to treatment.  Glucose was removed for the 
given time period.  Cell lysates were run on a 12% Tris-
Glycine SDS-PAGE gel.  Both phospo- and total rp-S6 were 
analyzed using immunoblotting.
Figure 4- Glucose refeeding after an 18 hour glucose free 
period restores rp-S6 phosphorylation in PC-3 cells.  The 
time required to restore rp-S6 phosphorylation was increased 
as compared to 1 hour of glucose deprivation. Cells were 
serum-starved for 1 hour prior to glucose removal.  After 18 
hours of glucose starvation, 25mM glucose or PBS was added 
for 15 minutes, 30 minutes, 1 hour or 2 hours. Cell lysates were 
run on a 12% Tris-Glycine SDS-PAGE gel. Phospho-rp-S6 
were analyzed using immunoblotting
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Figure 5- Low concentrations of glucose affect 
cell viability.  As time progresses, with higher 
concentrations of glucose, cell number increases.  
This indicates that low glucose may be inhibiting 
the cell cycle.  Cells were seeded in 96 well 
plates and allowed to attach overnight.  They 
were serum-starved for 1 hour prior to treatment.  
Treatments were for 18, 24 and 48 hours.  After 
these time periods, cell viability was assessed 
using the MTT assay according to the 
manufacturer’s instructions (Sigma-Aldrich). n=6. 
¾Investigate how nutrients affect 
the upstream pathways that activate 
mTOR.
¾Investigate the effects of nutrients 
on other downstream targets of 
mTOR including autophagy.
¾Manipulate other nutrients like 
lipids and investigate their effects 
on the mTOR pathway.
¾Perform Dietary Energy 
Restriction in a PTEN knockout 
mouse model of prostate cancer, 
examining the effects of DER on 
both tumorigenesis and the mTOR 
pathway.
¾Glucose removal will result in a 
decrease in the activity of the mTOR 
pathway.
¾This will result in a decreased 
activation of rp-S6, a downstream 
target of mTOR.
¾rp-S6 phosphorylation is a tightly 
regulated reversible event that can 
respond rapidly and efficiently to 
glucose status.
¾Low glucose concentrations will 
decrease prostate cancer cell 
viability.
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